Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both - PubMed (original) (raw)

. 2017 Jul 6;377(1):62-70.

doi: 10.1056/NEJMra1510062.

Affiliations

• PMID: 28679092
• DOI: 10.1056/NEJMra1510062

Free article

Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both

Janet Woodcock et al. N Engl J Med. 2017.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• The Master Protocol Concept.
  Redman MW, Allegra CJ. Redman MW, et al. Semin Oncol. 2015 Oct;42(5):724-30. doi: 10.1053/j.seminoncol.2015.07.009. Epub 2015 Jul 10. Semin Oncol. 2015. PMID: 26433553 Free PMC article. Review.
• The investigational drug steering committee.
  Ratain MJ. Ratain MJ. Clin Adv Hematol Oncol. 2007 Oct;5(10):779-80. Clin Adv Hematol Oncol. 2007. PMID: 17998895 No abstract available.
• Statistics and logistics: Design of Ebola vaccine trials in West Africa.
  Nason M. Nason M. Clin Trials. 2016 Feb;13(1):87-91. doi: 10.1177/1740774515620612. Epub 2016 Jan 14. Clin Trials. 2016. PMID: 26768560 No abstract available.
• An experimental design for the development of adaptive treatment strategies.
  Murphy SA. Murphy SA. Stat Med. 2005 May 30;24(10):1455-81. doi: 10.1002/sim.2022. Stat Med. 2005. PMID: 15586395
• Choosing cases and controls: the clinical epidemiology of "clinical investigation".
  Feinstein AR, Horwitz RI. Feinstein AR, et al. J Clin Invest. 1988 Jan;81(1):1-5. doi: 10.1172/JCI113279. J Clin Invest. 1988. PMID: 3275691 Free PMC article. Review. No abstract available.

Cited by

• The statistical design and analysis of pandemic platform trials: Implications for the future.
  Lindsell CJ, Shotwell M, Anstrom KJ, Berry S, Brittain E, Harrell FE, Geller N, Grund B, Hughes MD, Jagannathan P, Leifer E, Moser CB, Price KL, Proschan M, Stewart T, Thomas S, Touloumi G, LaVange L. Lindsell CJ, et al. J Clin Transl Sci. 2024 Oct 15;8(1):e155. doi: 10.1017/cts.2024.514. eCollection 2024. J Clin Transl Sci. 2024. PMID: 39540110 Free PMC article.
• Lessons from the HEALEY adaptive platform trial in amyotrophic lateral sclerosis.
  Paganoni S, Harkey B, Giacomelli E, Cudkowicz M; HEALEY ALS Platform Trial Study Group. Paganoni S, et al. Nat Aging. 2024 Nov;4(11):1512-1515. doi: 10.1038/s43587-024-00740-x. Nat Aging. 2024. PMID: 39487328 No abstract available.
• Personalized Treatment Strategies via Integration of Gene Expression Biomarkers in Molecular Profiling of Laryngeal Cancer.
  Maniaci A, Giurdanella G, Chiesa Estomba C, Mauramati S, Bertolin A, Lionello M, Mayo-Yanez M, Rizzo PB, Lechien JR, Lentini M. Maniaci A, et al. J Pers Med. 2024 Oct 10;14(10):1048. doi: 10.3390/jpm14101048. J Pers Med. 2024. PMID: 39452555 Free PMC article. Review.
• An innovative phase 2 chronic pain master protocol design to assess novel mechanisms in multiple pain types.
  Knopp KL, Downing AM, Anthony L, Chaterjee S, Price K, Sparks J. Knopp KL, et al. Pain Rep. 2024 Oct 16;9(6):e1203. doi: 10.1097/PR9.0000000000001203. eCollection 2024 Dec. Pain Rep. 2024. PMID: 39430683 Free PMC article.
• Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel disease.
  Ma C, Jairath V, Feagan BG, Peyrin-Biroulet L, Danese S, Sands BE, Panaccione R. Ma C, et al. Nat Rev Gastroenterol Hepatol. 2024 Nov;21(11):792-808. doi: 10.1038/s41575-024-00989-y. Epub 2024 Oct 8. Nat Rev Gastroenterol Hepatol. 2024. PMID: 39379665 Review.

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information